Latest News

Newer antiretroviral combinations including tenofovir alafenamide and dolutegravir are superior to older second-line options for children living with HIV, according to results from the CHAPAS-4 trial.
Researchers from the MRC Clinical Trials Unit at UCL and our partner institutions will showcase their latest work on HIV trials at the 12th International AIDS Society (IAS) Conference on HIV Science.
In the latest Trial Tak episode, we explore the REFINE trial which tests whether giving immunotherapy less often can still treat cancer effectively, whilst improving quality of life for patients.
The RID-TB: Treat trial, which will assess two newly-shortened treatment regimens along with additional treatment support, recruited its first participant last week at the Royal Free Hospital in London.
STOPCAP M1 meta-analysis reveals that the benefits of docetaxel vary depending on some characteristics of the prostate cancer.